TB-500 vs GHK-Cu
Side-by-side comparison of TB-500, GHK-Cu — mechanism, dosing, half-life, side effects, and research status.
| Attribute | TB-500 Thymosin Beta-4 Synthetic Analogue Recovery | GHK-Cu Glycyl-L-Histidyl-L-Lysine Copper Complex Recovery |
|---|---|---|
| Basics | ||
| Molecular type | Thymic Peptide Analogue | Copper-Binding Tripeptide |
| Amino acids | 43 | 3 |
| Molecular weight | 4,921 Da | 340.4 Da |
| Half-life | Long-acting (days) | Short (minutes to hours) |
| Route(s) | Subcutaneous, Intramuscular | Subcutaneous, Topical (skin), IV (research) |
| Mechanism & Research | ||
| Primary mechanism | TB-500's primary mechanism involves binding to G-actin (monomeric actin) through its conserved LKKTETQ sequence. By sequestering actin, it regulates cytoskeletal dynamics in ways that promote cell migration — a critical … | GHK-Cu forms a stable complex with copper(II), which is essential for its biological activity. The copper complex activates collagenase and other metalloproteinases that remodel damaged extracellular matrix while simulta… |
| Research status | Research Compound | Research Compound |
| Evidence summary | TB-500 research spans cardiac regeneration, wound healing, hair follicle regeneration, and musculoskeletal repair. Most data is preclinical. Phase 1/2 trials with native Thymosin Beta-4 for cardiac indications have been … | GHK-Cu is one of the most thoroughly researched cosmetic and wound-healing peptides. Topical GHK-Cu is commercially used in skincare. Deeper systemic applications (anti-aging, neuroprotection, systemic collagen support) … |
| Protocol & Dosing | ||
| Typical dose | 5–10 mg per injection | 1–2 mg/day (SC); topical as needed |
| Frequency | 2x per week (loading), then weekly | Daily |
| Duration | 4–8 weeks | 8–12 weeks |
| Timing | No specific timing requirement | Any time of day |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Prohibited (WADA S2) | Not Prohibited |
| Deeper reading | ||
| Related peptides | BPC-157, GHK-Cu, Thymosin Alpha-1 | BPC-157, Epithalon, LL-37 |
| Full profile | Read full TB-500 profile → | Read full GHK-Cu profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.